Pharma Marketletter - Lexapro offsets Celexa for Forest’s 2nd-qtr.

US drug firm Forest Laboratories has revealed excellent second-quarter 2003 results, but still only in line with consensus forecasts, with earnings per share up 45% at $0.48 and net profits also up 45% at $179.8 million, on sales growth of 30% to $605.7 million.

Most Popular
Business Plan Sample
Public Speaking: 7 Secrets Of Great Public Speakers
10 Jobs That Pay $30 An Hour
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes To Avoid

Forest’s antidepressant drug franchise contributed $475.7 million, comprising $284.7 million from its …
Want to read the whole article? You can purchase it here. It’s quick and easy.

source